Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Dow
Accenture
Moodys
US Army
McKinsey
UBS
Express Scripts

Generated: July 15, 2018

DrugPatentWatch Database Preview

Sodium nitroprusside - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for sodium nitroprusside and what is the scope of sodium nitroprusside patent protection?

Sodium nitroprusside
is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Micro Labs, Mylan Labs Ltd, Namigen Llc, Nexus Pharms, Renaissance Ssa Llc, Teva Parenteral, and Exela Pharma Scs Llc, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and twenty-six drug master file entries for sodium nitroprusside. Eight suppliers are listed for this compound.
Summary for sodium nitroprusside
Pharmacology for sodium nitroprusside
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for sodium nitroprusside

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Renaissance Ssa Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209834-001 Jun 26, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210763-001 Apr 17, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071961-001 Aug 1, 1988 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209493-001 Nov 7, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Fuji
Queensland Health
Harvard Business School
AstraZeneca
US Department of Justice
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.